Seal

CEUL029778: Duchenne Muscular Dystrophy: Current Understanding and Treatment

CureDuchenne

Approved

This course has been Approved in APTA AZ

Credit valid June 01, 2019 to May 31, 2020

Org Logo
Credit Description:

Duchenne muscular dystrophy is the most common terminal, childhood, genetic illness and at the same time is likely the most misunderstood condition. Recently, innovative research has uncovered many mysteries of Duchenne including its etiology, pathophysiology and treatment. As physical therapists and assistants, we continue to be one of the only treatment options for those who have Duchenne. It is vital that we have a thorough understanding of the disease and deliver appropriate treatments based on the current evidence. Inadequate understanding of the disease can lead to physical therapy related muscle injury to patients already at risk for severe muscle degeneration. Further education for physical therapists/assistants is crucial to our patients' lives. This course will explain the incidence, etiology, pathophysiology, progression and the stages of mobility of Duchenne. Physical therapy treatment, orthopedic management, activity modification and equipment selection will be covered. An update on current research and clinical trials will be provided to course participants.

Created On: Jan-17-2019 11:51 PM ET

Last Modified On: Mar-13-2026 07:23 AM ET

Application Website URL

Delivery Method: In Person

Date Approved: Apr-16-2019 12:17 PM ET

Credit Requested: 6.50

Credit Approved: 6.50

Public Access: CEUL is open to public

Credit Event Dates

Date Location Name City, State More Information
April 22, 2016 - April 22, 2016 Kansas City, MO Link  
October 27, 2017 - October 27, 2017 Lansing, MI Link  
June 01, 2019 - June 01, 2019 Phoenix, AZ Link